U.S. Basic Materials Stock News

NasdaqCM:IMTX
NasdaqCM:IMTXBiotechs

Immatics (NasdaqCM:IMTX) Quarterly Loss Of €50.5 Million Tests Bullish Growth Narratives

Immatics (NasdaqCM:IMTX) has reported its FY 2025 third quarter with total revenue of €5.2 million, basic EPS of a €0.42 loss, and net income excluding extra items showing a €50.5 million loss. This keeps the focus squarely on how far the business is from breakeven. Over recent periods, the company has seen quarterly revenue move between €18.6 million and €5.2 million, while basic EPS has ranged from a €0.38 profit to a €0.58 loss, highlighting the volatility in earnings as the pipeline...
NYSEAM:REI
NYSEAM:REIOil and Gas

Ring Energy (REI) TTM Loss Challenges Bullish Margin Recovery Narrative After FY 2025 Results

Ring Energy (REI) closed FY 2025 with Q4 revenue of US$78.0 million and a basic EPS loss of US$0.06, as net income excluding extra items came in at a loss of US$12.8 million. Over the past year, the company’s quarterly revenue has ranged between US$74.9 million and US$79.6 million, while basic EPS has shifted from a profit of US$0.17 in Q3 2024 to a loss of US$0.25 in Q3 2025 and a smaller loss in the latest quarter. With the trailing twelve month line still in loss territory, the key...
NYSE:GOTU
NYSE:GOTUConsumer Services

Gaotu Techedu Q3 Loss Narrows Yet Keeps Bullish Profitability Narratives Under Pressure

Gaotu Techedu (GOTU) just posted its latest FY 2025 numbers with Q3 revenue of C¥1.6b and a basic EPS loss of C¥0.61, alongside trailing twelve month revenue of C¥5.9b and a trailing EPS loss of C¥1.51 that keeps the story focused on loss levels rather than headline profit. Over the past several quarters, revenue has moved from C¥1.0b in Q2 2024 to C¥1.4b in Q2 2025 and C¥1.6b in Q3 2025, while quarterly basic EPS has ranged from a profit of C¥0.50 in Q1 2025 to losses of C¥0.88 and C¥0.61 in...
NYSE:SB
NYSE:SBShipping

Safe Bulkers (SB) Margin Compression Challenges Bullish Earnings Growth Narrative

Safe Bulkers (SB) has wrapped up FY 2025 with Q4 total revenue of US$72.6 million and basic EPS of US$0.10, alongside trailing 12 month revenue of US$275.7 million and EPS of US$0.30 that frame the latest quarter in a wider context. Over recent periods the company has seen quarterly revenue move between US$64.3 million and US$75.9 million, while basic EPS has ranged from a small quarterly loss of US$0.00 to US$0.22. This feeds directly into a trailing net profit margin of 11.1% compared to...
NasdaqCM:RDVT
NasdaqCM:RDVTSoftware

Red Violet (RDVT) Margin Expansion To 14.6% Tests Premium P/E Growth Narrative

Red Violet (RDVT) Posts FY 2025 Results With Higher Margins and Earnings Power Red Violet (RDVT) has wrapped up FY 2025 with fourth quarter revenue of US$23.4 million and basic EPS of US$0.20, while trailing twelve month revenue reached US$90.3 million and EPS came in at US$0.94 as earnings rose 87.8% over the past year. The company has seen quarterly revenue move from US$19.6 million and EPS of US$0.06 in Q4 2024 to US$23.4 million and EPS of US$0.20 in Q4 2025, alongside an improvement in...
NasdaqGS:SSYS
NasdaqGS:SSYSMachinery

Stratasys (SSYS) Q3 Loss Of US$55.6 Million Tests Profitability Narratives

Stratasys (SSYS) has just posted another loss making quarter, with Q3 FY 2025 revenue of US$137 million and a basic EPS loss of US$0.65, while trailing twelve month revenue sits at about US$561 million alongside a basic EPS loss of US$1.63. Over recent quarters the company has seen revenue move between US$136 million and US$150 million and quarterly basic EPS losses range from US$0.18 to US$0.65. This gives investors a clear view of a business that is still working through margin pressure...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Leonardo DRS (DRS) Valuation Check After Earnings Beat And Upgraded 2026 Guidance

Leonardo DRS (DRS) is back in focus after quarterly revenue and earnings topped expectations, supported by US$1.1b of new contract awards, higher 2026 revenue guidance and fresh recognition for its technology leadership. See our latest analysis for Leonardo DRS. The latest move takes the share price to US$45.82, after a 10.38% 1 month share price return and a 35.16% 3 month share price return. The 1 year total shareholder return of 55.08% and very large 3 year total shareholder return of...
NYSE:ARE
NYSE:AREHealth Care REITs

A Look At Alexandria Real Estate Equities (ARE) Valuation After Dividend Cut And US$1.4b Impairment-Driven Loss

Alexandria Real Estate Equities (ARE) has cut its quarterly dividend payout by 45% to US$0.72 per share after reporting a US$1.4b net loss for 2026, citing significant non cash property impairments. See our latest analysis for Alexandria Real Estate Equities. The dividend reduction and US$1.4b net loss have come alongside a weaker tape in the short term, with a 1-day share price return of a 3.34% decline and a 7-day share price return of a 6.04% decline. However, the 90-day share price return...
NYSEAM:UAMY
NYSEAM:UAMYMetals and Mining

Is It Too Late To Consider United States Antimony (UAMY) After Its Strong 1 Year Surge?

If you are wondering whether United States Antimony is still offering value after its recent run, you are not alone. This article is built to help you weigh that up clearly. The stock last closed at US$9.26, with returns of 3.9% over 7 days, a 4.0% decline over 30 days, a 56.2% gain year to date, and a very large 1 year return alongside a multi fold gain over 3 years. Recent coverage has focused on renewed investor interest in antimony and related materials, as the company features in...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Is It Too Late To Consider Credo Technology Group Holding (CRDO) After Its 173% Rally?

If you are wondering whether Credo Technology Group Holding is still attractively priced after its substantial share price rise, or whether much of the value may already be reflected in the price, this article is for you. The share price closed at US$114.74, with returns of 0.2% over the last week, 3.1% over the last month, a 19.9% decline year to date, and a 172.7% gain over the past year, along with a very large return over three years. This naturally raises questions about what is already...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Does Nvidia’s Arm Exit Quietly Recast Arm Holdings’ (ARM) AI Valuation Story?

In recent days, Arrcus announced a collaboration with Fujitsu and 1Finity around the FUJITSU-MONAKA Arm-based CPU, while Tensor and Arm unveiled a multi-year partnership to use more than 400 Arm cores in each planned Level 4 agentic AI personal Robocar due for commercial launch in 2026. At the same time, Nvidia’s complete exit from its Arm stake and a Malaysian anti-graft probe into a US$279 million blueprint deal have sharpened investor focus on Arm’s valuation, revenue mix, and governance...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Workday (WDAY) Valuation Check After Strong Earnings Softer Guidance Higher AI Spend And CEO Transition

Workday (WDAY) is back in the spotlight after strong quarterly results, softer guidance, increased AI spending, and a leadership change, with co founder Aneel Bhusri returning as CEO following Carl Eschenbach’s resignation. See our latest analysis for Workday. At a share price of US$147.18, Workday has seen a sharp reset recently, with a 90 day share price return of 33.09% decline and a 1 year total shareholder return of 42% decline. This suggests momentum has weakened even as earnings beats,...
NYSE:TGLS
NYSE:TGLSBuilding

Slowing Earnings Amid Revenue Growth Might Change The Case For Investing In Tecnoglass (TGLS)

Tecnoglass Inc. recently reported fourth-quarter 2025 results showing revenue of US$245.3 million, up from US$239.57 million, but with net income falling to US$26.11 million and diluted EPS from continuing operations dropping to US$0.57. Alongside confirming full-year 2025 revenue of US$983.61 million and completing a 7.31% share buyback, the company issued 2026 revenue guidance of US$1.06 billion to US$1.13 billion, which investors compared closely to softer earnings and margin...
NasdaqGM:WRD
NasdaqGM:WRDAuto Components

Does WeRide (WRD) Pausing Dubai Robotaxis Quietly Reframe Its Geopolitical Risk Playbook?

In late February 2026, WeRide paused its robotaxi operations in Dubai and shifted local staff to work-from-home arrangements amid escalating regional conflict, while maintaining regular services in Abu Dhabi and Riyadh and continuing its global investor outreach through appearances at major US technology conferences. This combination of operational caution in one Middle Eastern hub and ongoing expansion and visibility elsewhere highlights both WeRide’s exposure to geopolitical risk and its...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

Assessing LivaNova (LIVN) Valuation After Strong One Year Shareholder Returns

Why LivaNova Stock Is on Investors’ Radar LivaNova (LIVN) has drawn attention after recent trading, with the shares closing at $64.70. For context, the stock shows a 1 day return of 0.86% and a past week move of 8.87%. Over the past month the stock is down 1.87%, while over the past 3 months it is up 2.11%. Year to date, LivaNova’s total return is 6.70%, and the 1 year total return stands at 61.79%. See our latest analysis for LivaNova. Recent trading has been choppy, with a 1 day share price...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Is It Time To Reassess Intel (INTC) After A 121% One Year Share Price Jump

If you are wondering whether Intel's share price still reflects good value after a strong run, you are not alone. This article is designed to help you frame that question clearly. Intel recently closed at US$45.95, with returns of 1.1% over 7 days, a 6.7% decline over 30 days, and gains of 16.7% year to date and 121.4% over the past year. This naturally raises questions about both upside potential and changes in risk perception. Recent headlines around Intel have focused on its position in...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Is Ardelyx’s 2026 IBSRELA Outlook Altering The Investment Case For Ardelyx (ARDX)?

Ardelyx, Inc. has reported past full-year 2025 results, with revenue of US$407.32 million versus US$333.62 million a year earlier, while net loss widened to US$61.60 million and basic loss per share from continuing operations rose to US$0.26. Alongside these results, Ardelyx issued ambitious 2026 product revenue guidance for IBSRELA and XPHOZAH, highlighting management’s confidence in demand for its two commercial therapies. We’ll now examine how Ardelyx’s upbeat 2026 revenue outlook,...
NYSE:ROK
NYSE:ROKElectrical

Rockwell Automation Deal Highlights Growing Cybersecurity Role In Factory Modernization

Ronal Group has selected Rockwell Automation's secure remote access technology to modernize cybersecurity and regulatory compliance across its global manufacturing sites. The deployment focuses on centralized remote access with encrypted communication and role-based access control, addressing tightening regulations such as NIS2. This implementation highlights NYSE:ROK as a partner for large-scale manufacturers pursuing digital transformation and operational modernization. For investors...
NYSE:BMY
NYSE:BMYPharmaceuticals

Is It Too Late To Consider Bristol Myers Squibb (BMY) After Recent Share Price Strength?

Wondering if Bristol-Myers Squibb is offering good value at its current share price, or if you might be stepping in too late? This article walks through what the numbers actually say about the stock. The share price recently closed at US$60.74, with returns of 8.5% over the last 30 days and 13.6% year to date, so many investors are asking whether the current level still makes sense for new capital. Over the past year the stock returned 6.0%, and over 3 and 5 years it returned 4.7% and 22.7%...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

CorMedix (CRMD) Valuation Check After Recent Share Price Swings And Melinta Acquisition Narrative

CorMedix (CRMD) has been drawing attention after recent share price moves, with the stock at US$7.12 and returns mixed across time frames, including a 3% gain over the past day and weaker performance over the past month and 3 months. See our latest analysis for CorMedix. That 3% 1 day share price gain comes after a weaker spell, with a 30 day share price return of 13% decline and a year to date share price return of 41% decline. At the same time, the 3 year total shareholder return of 81%...
NYSE:CRCL
NYSE:CRCLSoftware

Circle Revenue And USDC Growth Weighed Against Regulation And Insider Sales

Circle Internet Group (NYSE:CRCL) reports 77% year over year revenue growth alongside a 72% rise in USDC stablecoin circulation. Regulatory developments, including the proposed GENIUS Act, are drawing attention to the company’s regulatory footing and business model. Executive share sales and insider trading activity coincide with Circle’s expansion through partnerships with firms such as Visa and Intuit. Circle sits at the center of the USDC stablecoin market, which ties digital tokens to...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

Copart (CPRT) Q2 EPS Slowdown Tests Bullish Profit Growth Narrative

Copart (CPRT) has put out its Q2 2026 scorecard, with revenue of about US$1.1 billion and basic EPS of US$0.36 setting the tone for the quarter. The company has seen quarterly revenue move between US$1.1 billion and US$1.2 billion over the past six periods, while basic EPS has ranged from roughly US$0.36 to US$0.42. This provides a clear view of how the top and bottom lines have tracked together. With trailing 12 month net margin sitting in the low 30s, this set of results keeps the focus...
NYSE:OSCR
NYSE:OSCRInsurance

A Look At Oscar Health’s Valuation After Reaffirmed 2026 Guidance At Raymond James Conference

Conference appearance and reaffirmed guidance draw fresh focus Oscar Health (OSCR) is back in the spotlight after management used its appearance at the 47th Annual Raymond James Institutional Investor Conference to reaffirm full year 2026 guidance, underscoring its current expectations for the business. This reaffirmation gives current and prospective shareholders a clearer view of how management is thinking about the next few quarters at a time when the stock’s recent performance has been...
NasdaqGS:KTOS
NasdaqGS:KTOSAerospace & Defense

Kratos Defense Deepens C UAS And Space Role With Nomad Integration

Kratos Defense & Security Solutions (NasdaqGS:KTOS) secured a new production contract for its counter unmanned aerial systems (C UAS) capabilities. The company expanded its satellite communications role as its OpenSpace platform was selected as the backbone of SSC Space Go. Kratos also completed the integration of Nomad Global Communication Systems operations into its broader business. For anyone tracking defense and space communications, Kratos sits at the intersection of C UAS technology...